Adult stem cell heart attack study updated at American Society for Hematology Meeting

December 11, 2007

Doctors are using patients' own bone marrow stem cells (progenitor cells) to treat the damage to cardiac muscle after a heart attack in a study at Emory University School of Medicine.

The study investigators--Emory cardiologist Arshed Quyyumi, MD, and hematologist/oncologist Edmund Waller, MD--will update their colleagues on its progress at the American Society of Hematology meeting in Atlanta next week.

"This is one of the first trials where patients receive varying doses of a cell population that is enriched for progenitor cells," says Dr. Waller, director of Emory's Bone Marrow and Stem Cell Transplant Center in the Emory Winship Cancer Institute.

Several groups of researchers around the world have reported clinical trials in which stem cells are used to try to restore the heart's pumping power, with mixed results.

Dr. Waller says his team plans to present information on the safety and feasibility of harvesting the bone marrow cells and the migration of stem cells in response to SDF-1, a signaling molecule released by damaged tissue that is believed to help guide the stem cells to sites where tissue repair is needed.

The clinical trial, which began in July 2006, has progressed halfway through the four planned groups of patients (40 total) who receive different amounts of sorted cells.

The magnetic sorting process, performed by Progenitor Cell Therapeutics, enriches for progenitor cells that doctors believe are able to help repair cardiac muscle.

In the clinical trial, patients receive the standard of care for their condition, including cardiac catheterization, angioplasty and implantation of a stent in the blocked artery. During catheterization, the bone marrow cells are introduced into the coronary artery where a blockage caused the patient's heart attack. To guide the bone marrow cells to the critical area, a balloon is inflated around the catheter, temporarily sealing off the artery from the rest of the circulation.

The patients are followed closely for the first year and then at regular intervals over a five-year period.
-end-
The study is funded by biotech company Amorcyte. Drs. Waller and Quyumi are paid consultants to Amorycyte.

A magazine article about the study is available at:
http://whsc.emory.edu/_pubs/em/2007summer/heal_thyself.html

A related poster session is scheduled for Dec. 8 at 5:30 p.m.

More information about the American Society of Hematology meeting is available at
http://www.hematology.org/meetings/2007/index.cfm.

Emory Health Sciences

Related Stem Cells Articles from Brightsurf:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

Read More: Stem Cells News and Stem Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.